Treating the substance-abusing suicidal patient

Annals of the New York Academy of Sciences

Volumn 932, Issue , 2001, Pages 78-93

  Cornelius, Jack R ^a,c   Salloum, Ihsan M ^a   Lynch, Kevin ^a   Clark, Duncan B ^a   John Manna, J ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c NONE   (United States)

Author keywords

Alcohol dependence; Antidepressants; Depression; Fluoxetine; Mood disorders; Substance abuse; Suicidal behavior; Suicide and substance abuse

Indexed keywords

ACAMPROSATE; ANTIDEPRESSANT AGENT; COCAINE; FLUOXETINE; NALTREXONE; SERTRALINE;

ALCOHOL ABUSE; COMORBIDITY; CONFERENCE PAPER; DEPRESSION; DRUG EFFICACY; HOSPITALIZATION; HUMAN; PSYCHIATRIC DIAGNOSIS; PSYCHOTHERAPY; RATING SCALE; SUBSTANCE ABUSE; SUICIDAL BEHAVIOR; SUICIDE ATTEMPT; TREATMENT INDICATION; TREATMENT OUTCOME;

CANNABIS; CANNABIS SATIVA;

EID: 0034995289     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2001.tb05799.x     Document Type: Conference Paper

References (57)

1. A hundred cases of suicide: Clinical aspects
2. Alcoholism and suicide
3. Psychiatric and medical diagnoses as risk factors for mortality in psychiatric patients: A case-control study
4. Suicide attempts and alcoholism
5. Mental disorders and comorbidity in suicide
6. Mental illness and suicide: A case-control study in East Taiwan
7. Comparative epidemiology of dependence on tobacco, alcohol, and controlled substances and inhalants: Basic findings from the National Comorbidity Study
8. Prevalence and comorbidity of mental disorders in persons making serious suicide attempts: A case-control study
9. Relationships of age and axis I diagnoses in victims of completed suicide
10. The co-occurrence of alcoholism and other psychiatric disorders in the general population and its impact on treatment
11. Comorbidity of mental disorders with alcohol and other drug abuse: Results from the Epidemiologic Catchment Area (ECA) study
12. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey
13. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey
14. Suicide and mental disorders: A case-control study of young men
15. Prevalence and psychiatric heterogeneity of alcoholism in a United States urban community
16. Suicide in alcoholism: A prospective study of 88 suicides. I. The multidimensional diagnosis at first admission
17. Multiple risk factors predict suicide in alcoholism
18. Characteristics of alcoholics who attempt suicide
19. Patterns of suicidality and alcohol use in alcoholics with major depression
20. Alcoholism, alcohol, and attempted suicide
21. Sociocultural and clinical characteristics of patients with comorbid depressions: A comparison of substance abuse and non-substance abuse diagnoses
22. Disproportionate suicidality in patients presenting with comorbid major depression and alcoholism
23. Gender effects on the clinical presentation of alcoholics at a psychiatric hospital
24. Clinical profile of comorbid major depression and alcohol use disorders in an initial psychiatric evaluation
25. Clinical profile and evaluation of comorbid major depression and alcoholism
26. Racial effects on the clinical presentation of alcoholics at a psychiatric hospital
27. Double-blind fluoxetine in depressed alcoholic smokers
28. Alcohol consumption in relation to other predictors of suicidality among adolescent inpatient girls
29. Suicidal ideation among the United States drinking population: Results from the National Longitudinal Alcohol Epidemiology Survey
30. Primary men alcoholics with histories of suicide attempts
31. An epidemiologic investigation of potential risk factors
32. Cocaine use associated with increased suicidal behavior in depressed alcoholics
33. Age of alcoholism onset. I. Relationship to psychopathology
34. The effect of depression on return to drinking
35. Relapse by alcohol abusers
36. Psychopathology as a predictor of treatment outcome in alcoholics
37. Dual diagnosis
38. Fluoxetine in depressed alcoholics: A double-blind, placebo-controlled trial
39. Fluoxetine trial in suicidal depressed alcoholics
40. Fluoxetine versus placebo in depressed alcoholics: A one-year follow-up study
41. Placebo-controlled study of sertraline in depressed recently abstinent alcoholics
42. Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics
43. Fluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers
44. Imipramine treatment of alcoholics with major depression: A placebo-controlled clinical trial
45. A double-blind placebo-controlled study of nortriptyline and bromocriptine in male alcoholics subtyped by comorbid psychiatric disorders
46. A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression
47. Fluoxetine treatment of cocaine abuse in heroin addicts
48. Fluoxetine in drug-dependent delinquents with major depression: An open trial
49. Fluoxetine versus placebo in depressed alcoholic cocaine abusers
50. Fluoxetine versus placebo to decrease the smoking of depressed alcoholics
51. Fluoxetine versus placebo for the marijuana use of depressed alcoholics
52. Psychotherapeutic considerations in pharmacological trials
53. Matching alcoholism treatments to client heterogeneity: Project MATCH three-year drinking outcomes
54. Predicting response to alcohol and drug abuse treatments
55. Predictors of antidepressant response in depressed alcoholic patients
56. Naltrexone utility in depressed alcoholics
57. Double-blind randomized multicenter trial of acamprosate in maintaining abstinence from alcohol